MB

MPM BioImpact Portfolio holdings

AUM $611M
1-Year Est. Return 29.61%
This Quarter Est. Return
1 Year Est. Return
+29.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$577M
AUM Growth
-$4.53M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
51
New
Increased
Reduced
Closed

Top Buys

1
+$13.8M
2
+$13.8M
3
+$10.5M
4
DBVT
DBV Technologies
DBVT
+$9.65M
5
EWTX icon
Edgewise Therapeutics
EWTX
+$8.07M

Top Sells

1
+$22.7M
2
+$18.2M
3
+$10.4M
4
TWST icon
Twist Bioscience
TWST
+$10.3M
5
NTRA icon
Natera
NTRA
+$9.82M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WVE icon
26
Wave Life Sciences
WVE
$2.7B
$9.78M 1.7%
1,505,262
-4,318
DBVT
27
DBV Technologies
DBVT
$817M
$9.65M 1.67%
+1,054,504
CNTX icon
28
Context Therapeutics
CNTX
$144M
$9.64M 1.67%
14,705,882
RCKT icon
29
Rocket Pharmaceuticals
RCKT
$429M
$9.56M 1.66%
3,903,081
+2,284,816
REPL icon
30
Replimune Group
REPL
$605M
$9.14M 1.58%
983,780
-3,256
NUVB icon
31
Nuvation Bio
NUVB
$2.16B
$9.01M 1.56%
4,622,590
-29,653
STOK icon
32
Stoke Therapeutics
STOK
$1.77B
$8.96M 1.55%
789,698
+95,710
SLDB icon
33
Solid Biosciences
SLDB
$453M
$7.96M 1.38%
1,634,569
-7,787
RLAY icon
34
Relay Therapeutics
RLAY
$1.4B
$7.9M 1.37%
2,282,680
-13,244
RNAC icon
35
Cartesian Therapeutics
RNAC
$199M
$7.13M 1.24%
686,007
-104,772
TSHA icon
36
Taysha Gene Therapies
TSHA
$1.38B
$6.82M 1.18%
+2,953,562
SRPT icon
37
Sarepta Therapeutics
SRPT
$2.39B
$5.5M 0.95%
+321,696
SLNO icon
38
Soleno Therapeutics
SLNO
$2.28B
$4.19M 0.73%
+50,000
VERU icon
39
Veru
VERU
$37.6M
$2.86M 0.5%
491,195
-168,078
HOWL icon
40
Werewolf Therapeutics
HOWL
$28.4M
$2.63M 0.45%
2,408,810
DSGN icon
41
Design Therapeutics
DSGN
$558M
$1.87M 0.32%
555,187
-7,756
RPTX icon
42
Repare Therapeutics
RPTX
$112M
$1.14M 0.2%
819,924
ADAP
43
DELISTED
Adaptimmune Therapeutics
ADAP
$1.06M 0.18%
4,411,821
-482,523
ACLX icon
44
Arcellx
ACLX
$4.04B
$2.44K ﹤0.01%
+37
LNTH icon
45
Lantheus
LNTH
$4.35B
– –
-232,387
TWST icon
46
Twist Bioscience
TWST
$2.45B
– –
-261,215
UTHR icon
47
United Therapeutics
UTHR
$20.5B
– –
-58,907
ALXO icon
48
ALX Oncology
ALXO
$72.1M
– –
-550,000
IDYA icon
49
IDEAYA Biosciences
IDYA
$3.25B
– –
-430,161
IOVA icon
50
Iovance Biotherapeutics
IOVA
$945M
– –
-2,708,582
1
2
3